IntegriChain
Overview
Pharma commercialization data and technology company whose ICyte platform aggregates channel (distributor, specialty pharmacy), patient, payer, and contract data to power gross-to-net, government pricing, and market access analytics. Combines SaaS products with consulting and outsourcing services.
Notable
Nordic Capital acquired a majority stake from Accel-KKR (announced November 2023); subsequently acquired BridgeView Life Sciences and Federal Compliance Solutions in 2024.
Key services
- channel data aggregation (distributor and specialty pharmacy)
- gross-to-net management and analytics
- government pricing and contracts
- patient services data analytics
- access analytics
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of IntegriChain? Share your experience in a short, confidential interview.
Share your experienceSources
- https://www.integrichain.com/platform
- https://www.nordiccapital.com/insights/press-releases/nordic-capital-acquires-majority-share-in-integrichain-the-only-fully-integrated-platform-for-pharma-commercialization-and-market-access/
- https://www.integrichain.com/about
- https://www.integrichain.com/products/data-driven-gross-to-net/
- https://www.integrichain.com/products/icyte-platform/
- https://www.integrichain.com/news/integrichain-launches-icyte-commercial-data-suite-improving-pharma-commercial-decisioning-and-go-to-market-profitability
- https://www.integrichain.com/